4.6 Review Book Chapter

Double-Strand Break End Resection and Repair Pathway Choice

Journal

ANNUAL REVIEW OF GENETICS, VOL 45
Volume 45, Issue -, Pages 247-271

Publisher

ANNUAL REVIEWS
DOI: 10.1146/annurev-genet-110410-132435

Keywords

homologous recombination; MRX/N; Sae2/CtIP/Ctp1; Ku; checkpoint; nonhomologous end joining

Funding

  1. NCI NIH HHS [CA092245] Funding Source: Medline
  2. NIGMS NIH HHS [GM077496, R01 GM041784-22, R01 GM041784, GM094386, R01 GM041784-23, GM041784] Funding Source: Medline
  3. NATIONAL CANCER INSTITUTE [R01CA092245] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094386, R01GM041784] Funding Source: NIH RePORTER

Ask authors/readers for more resources

DNA double-strand breaks (DSBs) are cytotoxic lesions that can result in mutagenic events or cell death if left unrepaired or repaired inappropriately. Cells use two major pathways for DSB repair: nonhomologous end joining (NHEJ) and homologous recombination (HR). The choice between these pathways depends on the phase of the cell cycle and the nature of the DSB ends. A critical determinant of repair pathway choice is the initiation of 5'-3' resection of DNA ends, which commits cells to homology-dependent repair, and prevents repair by classical NHEJ. Here, we review the components of the end resection machinery, the role of end structure, and the cell-cycle phase on resection and the interplay of end processing with NHEJ.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available